Lifenet Health

Lifenet Health, a Virginia Beach-based nonprofit manufacturer of regenerative medicine products and human tissue distribution, is a federal prime contractor supplying postmortem brain tissue, surgical implants, cellular therapies, and in vitro organ systems to the Department of Veterans Affairs, Department of Defense, and civilian research agencies under full-and-open competition with no set-aside designations. The vendor holds a corporate parent structure with one named subsidiary, Skin and Wound Allograft Institute LLC. Since 2001, Lifenet Health has accumulated 2,233 prime contract and IDV awards (100% of its federal footprint) valued at $90.8 million in combined potential value, with $20.7 million obligated to date, placing it as a critical supplier within federal medical and transplant procurement channels.

Lifenet Health's capability portfolio centers on the recovery, preservation, and distribution of human organs and tissues for transplantation and research. Representative prime work includes a $165 thousand purchase order from Veterans Integrated Service Network 6 (VISN 6) for postmortem brain tissue supporting PTSD research, awarded June 2026; a $244 thousand FDA delivery order for the Iontox Multi-Organ In Vitro System under the GSA Medical Equipment and Supplies (FSS-65-II-A) Schedule, issued September 2025; a $192.5 thousand VISN 6 purchase order for postmortem brain and related tissue for research, awarded October 2023; and a $139 thousand National Institute of Environmental Health Sciences purchase order for a Lifenet Health OOC Single Organ Standard System supporting environmental health research, issued August 2023. The vendor also supplies cellular bone matrix grafts, osteochondral grafts, saphenous veins, surgical implants, prosthetic limb components, and primary hepatocytes for orthopedic, transplant, and biomedical research applications.

Customer concentration reflects a military and veteran healthcare anchor. The top five funding agencies account for 43% of recent award volume: the Department of the Army Medical Command (190 awards, $45.1 million combined potential value), the Department of the Navy Bureau of Medicine and Surgery (344 awards, $2 million), VISN 6 (199 awards, $6.2 million), VISN 10 (124 awards, $1 million), and VISN 5 (96 awards, $513 thousand). By dollar value, the Army Medical Command dominates with $45.1 million, followed by the Defense Health Agency at $15.9 million and VISN 6 at $6.2 million—together accounting for 80% of combined potential value. The two rankings diverge meaningfully: the Navy places the highest volume by count (344 awards) but carries only $2 million in potential value, while Army and Defense Health Agency anchor the bulk of dollars despite lower award counts.

Lifenet Health places task orders under a portfolio of blanket purchase agreements and indefinite delivery contracts. The Medical Equipment and Supplies parent vehicle carries 19 task orders worth $422 thousand combined potential value. Blanket Purchase Agreement HT001416A0043 supports 13 task orders valued at $2.3 million. Blanket Purchase Agreement W9114F16A0003 anchors the largest single vehicle—7 task orders worth $25 million combined potential value—supporting tissue and supply procurement for military medical facilities. An Indefinite Delivery Contract VA24612D0152 carries 9 task orders worth $844 thousand. A single-award BPA with the Defense Health Agency for medical supplies supporting Walter Reed National Military Medical Center ran through July 2023 with a $6.5 million ceiling. A single-award BPA with VISN 6 for osteochondral grafts on consignment basis carries a $566 thousand ceiling with an ultimate completion date of August 2028. A $5 million blanket purchase agreement with the Department of the Army Medical Command supports tissue procurement including skin, bone, and corneal tissues.

Activity has declined significantly year over year—27 awards in 2022 declining to 14 awards in 2024, 5 in 2025, and 2 through June 2026. Only three awards with ultimate completion dates in the next twenty-four months carry combined potential value of $432 thousand, representing minimal near-term recompete exposure. The vendor's sub-award footprint is negligible (seven sub-awards across 2,240 total awards, or 0.3%)—Lifenet Health appears exclusively as a prime contractor, with minimal subcontracting activity. Recent sub-award citations show Lifenet Health supplying cellular bone matrix grafts, tendon grafts, and bone graft products to Atlantic Diving Supply Inc. as a subcontractor fulfilling downstream medical supply requirements, though the dollar values are not specified in the source.

The vendor's federal grant footprint is minimal—one sub-grant recipient award appears in the source: a Coverdell Stroke Grant sub-award from the Arkansas Department of Health, dated July 2025. No prime federal grant awards are cited in the source material. Lifenet Health's role is overwhelmingly transactional procurement of manufactured goods and biological materials rather than research, development, or service delivery through the grant pipeline.

Lifenet Health competes entirely under full-and-open competitive procurement without SBA set-asides, HUBZone designations, or other socioeconomic designations. All prime awards carry "No Set-Aside Used" notation in the source, and the vendor's nonprofit status and medical supply specialization place it outside the typical small-business and disadvantaged-business contracting pools. The vendor's federal market position relies on specialized capability in tissue recovery and preservation, established relationships across VA and DoD medical networks, and compliance with federal medical procurement standards rather than on set-aside protection or socioeconomic advantage.